95.11
前日終値:
$94.13
開ける:
$94.38
24時間の取引高:
2.89M
Relative Volume:
1.37
時価総額:
$20.14B
収益:
$7.68B
当期純損益:
$903.80M
株価収益率:
21.37
EPS:
4.45
ネットキャッシュフロー:
$1.14B
1週間 パフォーマンス:
-6.59%
1か月 パフォーマンス:
-7.47%
6か月 パフォーマンス:
-12.08%
1年 パフォーマンス:
-21.30%
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
名前
Zimmer Biomet Holdings Inc
セクター
電話
(574) 267-6131
住所
345 EAST MAIN STREET, WARSAW, IN
ZBH を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ZBH
Zimmer Biomet Holdings Inc
|
95.11 | 20.14B | 7.68B | 903.80M | 1.14B | 4.45 |
![]()
ABT
Abbott Laboratories
|
134.00 | 227.71B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
103.29 | 152.66B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
382.46 | 142.93B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
83.62 | 107.17B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
74.63 | 44.04B | 5.54B | 4.18B | 623.10M | 7.00 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-17 | アップグレード | JP Morgan | Neutral → Overweight |
2024-09-10 | 開始されました | Wolfe Research | Peer Perform |
2024-07-01 | ダウングレード | Piper Sandler | Overweight → Neutral |
2024-05-30 | 開始されました | Goldman | Neutral |
2024-05-21 | アップグレード | Argus | Hold → Buy |
2024-01-04 | ダウングレード | Evercore ISI | Outperform → In-line |
2023-10-20 | 開始されました | ROTH MKM | Neutral |
2023-08-28 | アップグレード | BTIG Research | Neutral → Buy |
2023-05-03 | アップグレード | BofA Securities | Underperform → Neutral |
2023-04-11 | アップグレード | Evercore ISI | In-line → Outperform |
2023-03-31 | アップグレード | Jefferies | Underperform → Hold |
2023-03-29 | 開始されました | UBS | Sell |
2023-03-10 | アップグレード | Piper Sandler | Neutral → Overweight |
2023-01-09 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
2023-01-05 | アップグレード | Raymond James | Mkt Perform → Outperform |
2023-01-03 | ダウングレード | Evercore ISI | Outperform → In-line |
2022-11-23 | アップグレード | Wells Fargo | Underweight → Equal Weight |
2022-10-18 | 開始されました | Barclays | Underweight |
2022-10-12 | 開始されました | Jefferies | Underperform |
2022-05-27 | ダウングレード | Needham | Buy → Hold |
2022-04-13 | ダウングレード | Truist | Buy → Hold |
2022-04-01 | ダウングレード | Citigroup | Buy → Neutral |
2022-03-02 | 再開されました | BofA Securities | Underperform |
2022-03-02 | ダウングレード | Loop Capital | Buy → Hold |
2022-02-08 | ダウングレード | Canaccord Genuity | Buy → Hold |
2022-02-08 | 繰り返されました | Citigroup | Buy |
2022-02-08 | 繰り返されました | Deutsche Bank | Hold |
2022-02-08 | 繰り返されました | JMP Securities | Mkt Outperform |
2022-02-08 | 繰り返されました | JP Morgan | Neutral |
2022-02-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
2022-02-08 | 繰り返されました | Stifel | Buy |
2022-02-08 | 繰り返されました | Truist | Buy |
2022-02-08 | 繰り返されました | UBS | Neutral |
2022-02-08 | 繰り返されました | Wells Fargo | Underweight |
2022-02-02 | ダウングレード | UBS | Buy → Neutral |
2022-01-19 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
2022-01-10 | ダウングレード | Mizuho | Buy → Neutral |
2022-01-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2022-01-04 | ダウングレード | Piper Sandler | Overweight → Neutral |
2021-12-10 | 開始されました | RBC Capital Mkts | Sector Perform |
2021-12-09 | ダウングレード | Needham | Strong Buy → Buy |
2021-12-07 | 開始されました | Loop Capital | Buy |
2021-11-23 | ダウングレード | Argus | Buy → Hold |
2021-09-14 | 再開されました | Raymond James | Mkt Perform |
2021-05-25 | 開始されました | Barclays | Overweight |
2021-04-09 | アップグレード | Northland Capital | Market Perform → Outperform |
2021-01-04 | アップグレード | Evercore ISI | In-line → Outperform |
2020-12-18 | 繰り返されました | Needham | Strong Buy |
2020-10-20 | 開始されました | Northland Capital | Market Perform |
2020-09-11 | 開始されました | Wolfe Research | Outperform |
2020-08-05 | 繰り返されました | Needham | Strong Buy |
2020-04-28 | ダウングレード | Guggenheim | Buy → Neutral |
2020-04-09 | ダウングレード | Evercore ISI | Outperform → In-line |
2020-04-07 | 繰り返されました | Needham | Strong Buy |
2020-03-05 | 開始されました | Citigroup | Buy |
2020-02-13 | 開始されました | Goldman | Buy |
2020-01-08 | 開始されました | SunTrust | Buy |
2020-01-07 | アップグレード | Piper Jaffray | Neutral → Overweight |
2020-01-07 | アップグレード | Piper Sandler | Neutral → Overweight |
2019-12-04 | アップグレード | Raymond James | Outperform → Strong Buy |
2019-10-07 | アップグレード | BTIG Research | Neutral → Buy |
2019-09-18 | アップグレード | Canaccord Genuity | Hold → Buy |
2019-08-12 | アップグレード | Argus | Hold → Buy |
2019-07-30 | アップグレード | Barclays | Underweight → Equal Weight |
2019-07-29 | アップグレード | Robert W. Baird | Neutral → Outperform |
2019-06-11 | アップグレード | Bernstein | Underperform → Mkt Perform |
2019-04-24 | アップグレード | Needham | Buy → Strong Buy |
すべてを表示
Zimmer Biomet Holdings Inc (ZBH) 最新ニュース
Collagen Meniscus Implant Market Is Booming So Rapidly - openPR.com
Zimmer Biomet Holdings (ZBH) Price Target Lowered by JMP Securities | ZBH Stock News - GuruFocus
Total Wrist Replacement Market Top Companies StudyZimmer - openPR.com
Zimmer Biomet (ZBH) Faces Price Target Reduction Amid Mixed Outlook | ZBH Stock News - GuruFocus
Zimmer biomet updates 2025 guidance with eps range of $7.90-$8.10 amid product launches - MSN
Dental Consumables Market Projected to Hit USD 70.55 Billion by 2032 Amid Rising Demand for Aesthetic and Restorative Dental Care – SNS Insider - GlobeNewswire Inc.
Decoding Zimmer Biomet Holdings Inc (ZBH): A Strategic SWOT Insi - GuruFocus
These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results - Benzinga
Zimmer Biomet Holdings (NYSE:ZBH) Q1 Earnings Rise, Revises 2025 Revenue Guidance Upward - Yahoo Finance
Zimmer Biomet Holdings (ZBH) Price Target Lowered by Stifel Analyst | ZBH Stock News - GuruFocus
Zimmer Biomet Holdings (ZBH) Maintains Outperform Rating Despite Price Target Cut | ZBH Stock News - GuruFocus
Morgan Stanley Adjusts Price Target for Zimmer Biomet Holdings (ZBH) | ZBH Stock News - GuruFocus
Zimmer Biomet stock target cut to $100 by Bernstein SocGen - Investing.com UK
Zimmer Biomet Holdings (ZBH) Receives Target Price Adjustment from JP Morgan | ZBH Stock News - GuruFocus
UBS maintains sell on Zimmer Biomet stock, holds $105 target By Investing.com - Investing.com UK
Zimmer Biomet Holdings (ZBH) Target Price Lowered by Wells Fargo | ZBH Stock News - GuruFocus
Zimmer Biomet (ZBH) Stock Target Lowered as Challenges Weigh In - GuruFocus
Morgan Stanley Reduces Zimmer Biomet (ZBH) Price Target to $95 | - GuruFocus
Zimmer Biomet Holdings (ZBH) Target Price Adjusted by Baird Anal - GuruFocus
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q1 2025 Earnings Call Transcript - Insider Monkey
Zimmer Biomet (ZBH) Target Price Cut by Raymond James Amid Future Tariff Concerns | ZBH Stock News - GuruFocus
Zimmer Biomet (ZBH) Sees Price Target Reduction Amid Q1 Updates - GuruFocus
Zimmer Biomet (ZBH) Price Target Revised by Stifel Analyst | ZBH Stock News - GuruFocus
Zimmer Biomet (ZBH) Faces Price Target Reduction Amid Tariff Con - GuruFocus
Zimmer Biomet flags $60m-$80m tariff impact on 2025 profits - Yahoo Finance
Zimmer Biomet: Stronger Cash Flows Needed Before The Stock Rebounds (NYSE:ZBH) - Seeking Alpha
Zimmer Biomet Q1 2025 net sales increase 1.1% to USD 1.909 bn - Medical Buyer
Zimmer Biomet Holdings First Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Morgan Stanley cuts Zimmer Biomet stock target to $95 By Investing.com - Investing.com India
Zimmer Biomet expects $60M to $80M tariff impact this year - Yahoo Finance
Zimmer Biomet falls 10% after narrowing its 2025 EPS guidance range - MSN
Zimmer Biomet Holdings Inc (ZBH) Q1 2025 Earnings Call Highlights: Navigating Growth Amid ... - Yahoo Finance
Zimmer Biomet Holdings Inc (ZBH) Q1 2025 Earnings Call Highlights: Navigating Growth Amid ... By GuruFocus - Investing.com Canada
Zimmer Biomet Holdings Inc (ZBH) Q1 2025 Earnings Call Highlights: Navigating Growth Amid Tariff Challenges - GuruFocus
Zimmer Biomet's Q1 earnings highlight strategic growth in orthopedic sector - Today's Medical Developments
Zimmer Biomet (ZBH) Shares Plummet 12% on Reduced Earnings Outlook - GuruFocus
Zimmer Biomet Reports Q1 2025 Financial Results - TipRanks
Zimmer: Q1 Earnings Snapshot - MySA
Earnings call transcript: Zimmer Biomet Q1 2025 sees stock fall despite earnings beat - Investing.com Nigeria
Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors - MSN
Zimmer Biomet (ZBH) Faces Price Target Cut Amid Concerns Over Future Growth | ZBH Stock News - GuruFocus
U.S. Indexes Decreased Monday; Zimmer Biomet Holdings Took Biggest Hit - Barron's
Citi cuts Zimmer Biomet stock target to $104, retains neutral stance - Investing.com
Hip Implant Maker Zimmer Biomet Cuts Annual Profit Forecast On Paragon 28 Deal - Benzinga
Zimmer Biomet stock target cut to $102 by Evercore ISI - Investing.com UK
Zimmer Biomet (ZBH) Price Target Reduced by RBC Capital | ZBH Stock News - GuruFocus
Zimmer Biomet (ZBH) Faces Price Target Cut and Mixed Outlook | ZBH Stock News - GuruFocus
Zimmer Biomet Seeks to Accelerate Knee Growth - Morningstar
Citi Adjusts Zimmer Biomet (ZBH) Price Target While Maintaining Neutral Stance | ZBH Stock News - GuruFocus
Zimmer Biomet (ZBH) Sees Growth from Product Launches and Acquisition - GuruFocus
Citigroup Cuts Zimmer Biomet Price Target to $104 From $118 - marketscreener.com
Zimmer Biomet Holdings Inc (ZBH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):